文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

羟嗪在院前吗啡镇痛中减轻患者焦虑的作用:一项前瞻性随机双盲研究

Hydroxyzine for lowering patient's anxiety during prehospital morphine analgesia: A prospective randomized double blind study.
PubMed 文献 · Am J Emerg Med · 2021-10-01
一句话结论院前急性重度疼痛患者中,吗啡联合羟嗪较安慰剂未改善15分钟镇痛或焦虑,作者认为据此无使用指征。

本研究为前瞻性随机双盲对照研究,纳入院前急性疼痛且数字评价量表(NRS)评分≥6分的患者140例,比较常规静脉吗啡滴定联合羟嗪与安慰剂对疼痛和焦虑的影响,焦虑采用自评面部焦虑量表(FAS,0-4分)测量。主要终点为首次注射后15分钟疼痛缓解(NRS≤3分)的患者比例:羟嗪组51%(95%CI 39%-63%)vs 安慰剂组52%(95%CI 40%-64%)。羟嗪组91%(95%CI 83%-98%)报告焦虑未加重 vs 安慰剂组78%(95%CI 68%-88%),p>0.05。不良事件轻微且两组无差异(羟嗪组6% vs 安慰剂组14%)。作者结论为院前情况下吗啡加用羟嗪未减轻急性重度疼痛患者的疼痛或焦虑,据其结果无使用指征。

要点

  • 院前急性疼痛NRS≥6分患者中,吗啡联合羟嗪15分钟疼痛缓解(NRS≤3分)比例为51%(95%CI 39%-63%),安慰剂组为52%(95%CI 40%-64%)。
  • 羟嗪组91%(95%CI 83%-98%)报告焦虑未加重,安慰剂组78%(95%CI 68%-88%),差异无统计学意义(p>0.05)。
  • 不良事件轻微,羟嗪组6% vs 安慰剂组14%,两组无差异。
  • 作者结论认为,院前吗啡镇痛中加用羟嗪未减轻疼痛或焦虑,据其结果无使用指征。

适用人群与场景

  • 院前急性疼痛患者,疼痛数字评价量表(NRS,0-10分)评分≥6分。

诊断标准与关键阈值

  • 疼痛采用0-10分口头数字评价量表(NRS)评估,纳入评分≥6分者。
  • 焦虑采用自评面部焦虑量表(FAS)评估,评分范围0-4分。

研究设计与关键结果

  • 研究类型:前瞻性随机双盲对照研究;样本量140例;人群为院前急性疼痛NRS≥6分患者。
  • 干预与对照:常规静脉吗啡滴定联合羟嗪 vs 联合安慰剂。
  • 主要终点:首次注射后15分钟疼痛缓解(NRS≤3分)比例,羟嗪组51%(95%CI 39%-63%)vs 安慰剂组52%(95%CI 40%-64%)。
  • 焦虑未加重比例:羟嗪组91%(95%CI 83%-98%)vs 安慰剂组78%(95%CI 68%-88%),p>0.05。
  • 不良事件:轻微,羟嗪组6% vs 安慰剂组14%,两组无差异。

证据类型、等级与局限

  • 证据类型:前瞻性随机双盲对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,院前情况下吗啡加用羟嗪未减轻急性重度疼痛患者的疼痛或焦虑,据其结果无使用指征。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Hydroxyzine is an antihistamine drug used for symptomatic relief of anxiety and tension. We hypothesized that managing the anxiety of patients with severe pain by adding hydroxyzine to a conventional intravenous morphine titration would relieve their pain more effectively.

METHODS: This was a randomized, double-blind, controlled group study of prehospital patients with acute pain scored greater than or equal to 6 on a 0-10 verbal numeric rating scale (NRS). Patients'anxiety was measured with the self-reported Face Anxiety Scale (FAS) ranking from 0 to 4. The percentage of patients with pain relief (NRS score ≤ 3) 15 min after the first injection was the primary outcome.

RESULTS: One hundred forty patients were enrolled. Fifty-one percent (95% CI 39% to 63%) of hydroxyzine patients versus 52% (95% CI 40% to 64%) of placebo patients reported a pain numeric rating scale score of 3 or lower at 15 min. Ninety-one percent (95% CI 83% to 98%) of patients receiving hydroxyzine reported no more severe anxiety versus 78% (95% CI 68% to 88%) of patients with placebo (p > 0.05). Adverse events were minor, with no difference between groups (6% in hydroxyzine patients and 14% in placebo patients).

CONCLUSION: Addition of hydroxyzine to morphine in the prehospital setting did not reduce pain or anxiety in patients with acute severe pain and therefore is not indicated based on our results.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Houze-Cerfon CH, Balen F, Houze-Cerfon V, et al. Hydroxyzine for lowering patient's anxiety during prehospital morphine analgesia: A prospective randomized double blind study. Am J Emerg Med. 2021. PMID: 34879499. doi:10.1016/j.ajem.2021.09.061

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。